文献速递流行病学与生物统计医学教育与科研方法

北欧国家医科大学及大学医院主导的临床试验结果报告常缺失或延迟

Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed.
PubMed 文献 · J Clin Epidemiol · 2025-02-01

这项横断面研究纳入2016至2019年完成的2112项由北欧医科大学或大学医院主导的注册临床试验,系统评估结果报告情况。随访期内78.1%报告了任何结果,仅51.9%在全球完成日期后2年内报告,仅2.3%在1年内于注册平台发布摘要结果,中位报告时间为690天。作者认为结果缺失和延迟是普遍问题,需机构、资助方和政策制定者支持确保报告。

要点

  • 2112项试验中78.1%报告任何结果,51.9%在完成2年内报告,2.3%在1年内注册平台发布摘要结果。
  • 从全球完成日期到结果报告的中位时间为690天(四分位距1103天)。
  • 丹麦贡献约半数试验,各机构报告表现差异大,作者呼吁支持试验团队确保报告。

核心结论

  • 学术主导临床试验的结果缺失和延迟报告在北欧国家是普遍问题,机构、资助方和政策制定者需支持试验团队、确保法规依从并在结果永久丢失前保障报告。

研究设计与样本

  • 横断面研究纳入2016至2019年完成、在欧盟临床试验注册库和/或ClinicalTrials.gov注册、由丹麦、芬兰、冰岛、挪威或瑞典的医学院校大学或大学医院主导的试验,不限干预类型。
  • 通过试验注册库识别已发布的摘要结果,并系统手动检索结果发表(如期刊论文、预印本),报告比例及95%置信区间、中位数及四分位距。
  • 方案见 https://osf.io/wua3r。

主要发现

  • 2112项纳入试验中,1650项(78.1%,95%CI 76.3%-79.8%)在随访期内报告了任何结果。
  • 1097项(51.9%,95%CI 49.8%-54.1%)在全球完成日期后2年内报告了任何结果。
  • 48项(2.3%,95%CI 1.7%-3.0%)在1年内于注册平台发布摘要结果。
  • 从全球完成日期到结果报告的中位时间为690天(四分位距1103天)。
  • ClinicalTrials.gov注册的试验中856/1681(50.9%)为前瞻性注册,丹麦贡献约半数试验,各机构报告表现差异大。

局限性

  • 研究依赖试验注册库信息,该信息可能不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To systematically evaluate timely reporting of clinical trial results at medical universities and university hospitals in the Nordic countries. STUDY DESIGN AND SETTING: In this cross-sectional study, we included trials (regardless of intervention) registered in the European Union (EU) Clinical Trials Registry and/or ClinicalTrials.gov, completed 2016-2019 and led by a university with medical faculty or university hospital in Denmark, Finland, Iceland, Norway, or Sweden. We identified summary results posted at the trial registries and conducted systematic manual searches for results publications (eg, journal articles, preprints). We present proportions with 95% confidence intervals (CI) and medians with interquartile range (IQR). PROTOCOL: https://osf.io/wua3r. RESULTS: Among 2112 included clinical trials, 1650 (78.1%, 95% CI 76.3%-79.8%) reported any results during our follow-up; 1097 (51.9%, 95% CI 49.8%-54.1%) reported any results within 2 years of the global completion date; and 48 (2.3%, 95% CI 1.7%-3.0%) posted summary results in the registry within 1 year. The median time from global completion date to results reporting was 690 days (IQR 1103). 856/1681 (50.9%) of ClinicalTrials.gov registrations were prospective. Denmark contributed approximately half of all trials. Reporting performance varied widely between institutions. CONCLUSION: Missing and delayed results reporting of academically led clinical trials are a pervasive problem in the Nordic countries. We relied on trial registry information, which can be incomplete. Institutions, funders, and policymakers need to support trial teams, ensure regulation adherence, and secure trial reporting before results are permanently lost. PLAIN LANGUAGE SUMMARY: Reporting of results from clinical trials is necessary for evidence-based clinical decision-making. We followed up reporting of clinical trials in the Nordic countries sponsored by medical universities and university hospitals. Of 2112 studies completed 2016-2019 in two major trials registries, about half reported results in any form within 24 months, and more than one in five did not report results at all. These results show that there is a need for improvement in the reporting of Nordic clinical trials.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Nilsonne G, Wieschowski S, DeVito NJ, et al. Results reporting for clinical trials led by medical universities and university hospitals in the nordic countries was often missing or delayed. J Clin Epidemiol. 2025. PMID: 39900256. doi:10.1016/j.jclinepi.2025.111710

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。